← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 1999Last known activity
Sep 2, 2021
Timeline
1960s
- Jun 1, 1962
Danish Heart Foundation— Founded
Drugs by trial phase (30 distinct, 22 trials)
Phase 4 (16 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Atrial Fibrillation
- Cardiovascular Diseases
- Coronary Artery Disease
- Depression
- Depressive Disorder
- Diabetes Mellitus, Type 2
- Embolism
- Heart Diseases
- Heart Failure
- Hyperglycemia
- Hypertension
- Infarction
- Intermittent Claudication
- Kidney Failure, Chronic
- Myocardial Infarction
- Myocardial Ischemia
- Non-ST Elevated Myocardial Infarction
- Pulmonary Embolism
- Renal Insufficiency
- ST Elevation Myocardial Infarction
- Thromboembolism
- Thrombosis
- Vascular Diseases
- Venous Thromboembolism
- Venous Thrombosis
Recent trials (28)
- NCT05084235CollaboratorPhase 2Sep 2, 2021
- NCT05042973CollaboratorPhase 2Sep 2, 2021
- NCT04615754CollaboratorPhase 2Aug 18, 2020
- NCT03862859CollaboratorPhase 4Sep 30, 2019
- NCT03862859Study chairPhase 4Sep 30, 2019
- NCT03778554CollaboratorPhase 4Dec 17, 2018
- NCT04149990CollaboratorPhase 2Oct 12, 2018
- NCT03405831CollaboratorPhase 4Apr 17, 2018
- NCT03514108Study chairPhase 4Mar 1, 2018
- NCT03514108CollaboratorPhase 4Mar 1, 2018
- NCT03129555Lead sponsorPhase 4May 1, 2017
- NCT03129490Study chairPhase 4May 1, 2017
- NCT03129490Reponsible party - principal investigatorPhase 4May 1, 2017
- NCT03129490Lead sponsorPhase 4May 1, 2017
- NCT03129555Reponsible party - principal investigatorPhase 4May 1, 2017
Details
- Founded
- Copenhagen, DK Jun 1, 1962
- Last known activity
- Sep 2, 2021